Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity

Journal of Rehabilitation Medicine

Volumn 43, Issue 11, 2011, Pages 1032-1037

  Baguley, Ian J ^a   Nott, Melissa T ^a   Turner Stokes, Lynne ^b   Graaff, Stephen De ^c   Katrak, Pesi ^d   McCrory, Paul ^e   Abadal, Monica De ^f   Hughes, Andrew ^g  

^a UNIVERSITY OF SYDNEY   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Caulfield General Medical Centre   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f IPSEN   (France)

^g AUSTIN HEALTH   (Australia)

Author keywords

Botulinum toxin A; Clinical reasoning; Muscle spasticity; Rehabilitation; Stroke; Upper limb

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; ARM; ARTICLE; CLINICAL PRACTICE; DECISION MAKING; EVIDENCE BASED MEDICINE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; SPASTICITY; STROKE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS, TYPE A; DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; STROKE; TREATMENT OUTCOME; UPPER EXTREMITY;

EID: 84855909354     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0885     Document Type: Article

References (26)

1. Suputtitada A, Suwanwela N. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity. Disabil Rehabil 2005; 27: 176-184. (Pubitemid 40468158)
2. Mayer NH, Whyte J, Wannstedt G, Ellis CA. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. Arch Phys Med Rehabil 2008; 89: 982-987. (Pubitemid 351618387)
3. Francisco GE, Boake C, Vaughn A. Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques. Am J Phys Med Rehabil 2002; 81: 355-363. (Pubitemid 34412072)
4. Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001; 8: 559-565. (Pubitemid 35015221)
5. McCrory PR, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebocontrolled study of the effects on quality of life and other personcentred outcomes. J Rehabil Med 2009; 41: 536-544.
6. Bhakta BB, O'Connor RJ, Cozens JA. Associated reactions after stroke: a randomized controlled trial of the effect of botulinum toxin type A. J Rehabil Med 2008; 40: 36-41. (Pubitemid 351200731)
7. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiat 2000; 69: 217-221. (Pubitemid 30466027)
8. Childers MK, Brashear A, Jozefczyk P, Reding M, Alexander D, Good D, et al. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. Arch Phys Med Rehabil 2004; 85: 1063-1069. (Pubitemid 38962361)
9. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebocontrolled trial. Neurol 1996; 46: 1306-1310. (Pubitemid 26159292)
10. Smith SJ, Ellis E, White S, Moore AP. A double-blind placebocontrolled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000; 14: 5-13. (Pubitemid 30072216)
11. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002; 347: 395-400. (Pubitemid 34851831)
12. Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, et al. A randomized, double-blind, placebo-controlled, doseranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000; 31: 2402-2406.
13. Bakheit AMO. Botulinum toxin in the management of childhood muscle spasticity: comparison of clinical practice of 17 treatment centres. Eur J Neurol 2003; 10: 415-419. (Pubitemid 41754762)
14. DeJong G, Horn SD, Conroy B, Nichols DG, Healton EB. Opening the black box of poststroke rehabilitation: stroke rehabilitation patients, processes, and outcomes. Arch Phys Med Rehabil 2005; Suppl 2 86: S1-S7. (Pubitemid 43040965)
15. Whyte J, Hart T. It's more than a black box; it's a Russian doll: defining rehabilitation treatments. Am J Phys Med Rehabil 2003; 82: 639-652 (Pubitemid 36890413)
16. Bohannon RW, Smith MB. Interrater reliability of a Modified Ashworth Scale of muscle spasticity. Phys Ther 1987; 67: 206-207. (Pubitemid 17026064)
17. Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory PR, et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. J Rehabil Med 2010; 42: 81-89.
18. Sheean G, Lannin NA, Turner-Stokes L, Rawicki B, Snow BJ. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol 2010; 17: 74-93.
19. Fehlings D, Novak I, Berweck S, Hoare B, Stott NS, Russo RN. Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement. Eur J Neurol 2010; 17: 38-56.
20. Love SC, Novak I, Kentish M, Desloovere K, Heinen F, Molenaers G, et al. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. Eur J Neurol 2010; 17: 9-37.
21. Kiresuk TJ, Sherman RE. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Comm Ment Health J 1968; 4: 443-453.
22. Bakheit AM, Zakine B, Maisonobe P, Aymard C, Fhedoroff K, Hefter H, et al. The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey. Int J Rehabil Res 2010; 33: 199-204.
23. Burridge JH, Wood DE, Hermens HJ, Voerman GE, Johnson GR, van Wijck F, et al. Theoretical and methodological considerations in the measurement of spasticity. Disabil Rehabil 2005; 27: 69-80. (Pubitemid 40124837)
24. Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Disabil Rehabil 2005; 27: 7-18. (Pubitemid 40124835)
25. Elovic EP, Simone LK, Zafonte R. Outcome assessment for spasticity management in the patient with traumatic brain injury: the state of the art. J Head Trauma Rehabil 2004; 19: 155-177. (Pubitemid 38437140)
26. Ivanhoe CB, Reistetter TA. Spasticity: the misunderstood part of the upper motor neuron syndrome. Am J Phys Med Rehabil 2004; Suppl 10 83: S3-S9. (Pubitemid 39281263)